Elucidating drug repurposing in non-small cell lung cancer via microarray-based profiling
碩士 === 國立陽明大學 === 生物藥學研究所 === 103 === Lung cancer is the leading cause of cancer death around the world. Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancers. In the present clinical treatment, patients receive cisplatin plus gemcitabine or pemetrexed for lung squamo...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2015
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/02155410213293017670 |